{"id":205037,"name":"INSTITUTE FOR GENE THERAPIES","slug":"institute-for-gene-therapies","state":"DC","country":"United States of America","description":"Advocacy organization","totalSpending":1150000,"filings":26,"yearlySpending":[{"year":2020,"income":110000},{"year":2021,"income":190000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":250000}],"issues":["HCR"],"firms":["THORN RUN PARTNERS"],"lobbyists":["ANDREW ROSENBERG","BEAU SCHUYLER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to regulatory and reimbursement policies for innovative gene therapies.","Issues related to regulatory and reimbursement policies for innovative gene therapies.","Issues related to regulatory and reimbursement policies for innovative gene therapies.","Issues related to regulatory and reimbursement policies for innovative gene therapies.","Issues related to regulatory and reimbursement policies for innovative gene therapies."],"years":[2020,2021,2022,2023,2024,2025]}